Innoterix Labs’ Post

Incentive (in)compatibility & time inconsistency are the two impediments in traditional R&D and Access to combat #AMR. An interesting read on what public-private partnerships have to offer here:

A new important chapter can begin in TBVI's and Biofabri's joint effort in developing a new TB vaccine for infants

News Link: https://lnkd.in/gAqR8hc2 #CancerCureVaccines #CancerVaccineTrial #UCLH #MelanomamRNAVaccines #mRNA4157 #BritainHerald #PersonalisedmRNACancerVaccine #StudyonCancerCureVaccines

A milestone for SOD1-MND care today as the EMA recommends tofersen approval, 26 years since the last EU-approved MND treatment. Pending European Commission approval, this is a significant step forward in #MND care. We will continue to work together with Motor Neurone Disease (MND) Association and My Name'5 Doddie Foundation to understand this outcome and what it means for people with the SOD1 type of MND in the UK and our next steps. https://lnkd.in/eiCDXstM

Find out how IMed Consultancy supported SureScreen Diagnostics in the transition from professional use to self-testing for their SARS-CoV-2 Rapid Antigen Test Cassette in the midst of the pandemic here: https://lnkd.in/d9UVFqug #imedconsultancy #casestudy #surescreen #surecreendiagnostic #covid19 #pandemic #rapidantigentest #CEmarking

Great to see a new publication on performance evaluation for a #POC #CRP test versus the laboratory test. Thanks to co-authors and study investigators, #Alasdair #Gray (#Royal #Infirmary #Edinburgh, #EMERGE), #James #Harnett and #Gregor #Cameron (#UCL) and #Phil #Moss (#St #Georges) for their excellent support. Quantitative point of care CRP tests are a simple and effective way to obtain fast, laboratory equivalent results at the point of patient care. This is especially useful in secondary care, and also in primary/ community care where the result can help with effective, evidence-based antimicrobial prescribing supporting the #UK #AMR #Strategy. #JEMMDx can help support clinical trials and their publication to enable clients to demonstrate test performance and value in transforming patient pathways. #CRP #AMR #EMERGE #NPT #POC https://lnkd.in/eCyj3EtX

We're thrilled to attend the 2024 International HBV Meeting in Chicago next week! As part of our commitment to advancing research and treatment for viral and life-threatening illnesses, we're hosting a panel discussion on the critical role of patient perspectives in Hepatitis B research and treatment. Anne Kasmar, Parexel's Senior Vice President and Therapeutic Head of Infectious Disease, will moderate the discussion with a panel of experts representing diverse experiences in the Hepatitis B research community: - Patient leader- Wendy Lo, Patient Advocate - Foundation leader- Chari Cohen, President, Hepatitis B Foundation - Industry leader- Christine Livingston, Scientific Director, GSK - Clinician- Roger Inouye, Senior Medical Director, Parexel - Academic researcher- Thomas Tu, Group Leader, Storr Liver Centre, The Westmead Institute Together, we'll explore how patient insights drive innovation, improve trial design, and shape research priorities in the fight against Hepatitis B. We'll discuss current challenges in Hepatitis B research and treatment and how increased patient engagement and collaboration can help overcome these obstacles. We look forward to a transformative discussion highlighting how patients will reshape the future of Hepatitis B research and treatment. Let's embrace a patient-guided approach across all phases of research to propel progress in treating and finding the cure for Hepatitis B! #HepatitisB #HepB #PatientPerspectives #PatientFirst

We're thrilled to attend the 2024 International HBV Meeting in Chicago next week! As part of our commitment to advancing research and treatment for viral and life-threatening illnesses, we're hosting a panel discussion on the critical role of patient perspectives in Hepatitis B research and treatment. Anne Kasmar, Parexel's Senior Vice President and Therapeutic Head of Infectious Disease, will moderate the discussion with a panel of experts representing diverse experiences in the Hepatitis B research community: - Patient leader- Wendy Lo, Patient Advocate - Foundation leader- Chari Cohen, President, Hepatitis B Foundation - Industry leader- Christine Livingston, Scientific Director, GSK - Clinician- Roger Inouye, Senior Medical Director, Parexel - Academic researcher- Thomas Tu, Group Leader, Storr Liver Centre, The Westmead Institute Together, we'll explore how patient insights drive innovation, improve trial design, and shape research priorities in the fight against Hepatitis B. We'll discuss current challenges in Hepatitis B research and treatment and how increased patient engagement and collaboration can help overcome these obstacles. We look forward to a transformative discussion highlighting how patients will reshape the future of Hepatitis B research and treatment. Let's embrace a patient-guided approach across all phases of research to propel progress in treating and finding the cure for Hepatitis B! #HepatitisB #HepB #PatientPerspectives #PatientFirst

Save and share CRITQD Are you enjoying this daily series of quick informative pearls? Let me know if there's something specific that you'd like me to cover. #meded #FOAMed #criticalcare #emergencymedicine

How far off is your AAV titer measurement? Check it out with Teknova's new PCR sample prep kit. You might actually be closer to the titer you need, but your current method only accounts for a fraction of it.